At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Market Closed 08-28 16:00:00 EDT
6.96
-0.30
-4.13%
盘后7.03
+0.07+1.01%
19:30 EDT
High7.29Low6.91Vol1.26M
Open7.23D1 Closing7.26Amplitude5.17%
Mkt Cap468.69MTradable Cap347.12MTotal Shares67.34M
T/O8.85MT/O Rate2.53%Tradable Shares49.87M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

4basebio Strikes Genezen Pact to Advance Synthetic DNA for Viral Vector Manufacturing
TIPRANKS  ·  08-26
4basebio Strikes Genezen Pact to Advance Synthetic DNA for Viral Vector Manufacturing
WuXi AppTec Contains Cyber Breach in DNA-Encoded Library Platform
TIPRANKS  ·  08-24
WuXi AppTec Contains Cyber Breach in DNA-Encoded Library Platform
DNA X Q2 EPS $(0.91) Up From $(14.15) YoY
Benzinga Earnings  ·  08-20
DNA X Q2 EPS $(0.91) Up From $(14.15) YoY
DNA X, Inc. Reports Second Quarter 2026 Financial Results
GlobeNewswire  ·  08-20
DNA X, Inc. Reports Second Quarter 2026 Financial Results
Ginkgo Bioworks Holdings Cut to Hold from Buy by TD Cowen
Dow Jones  ·  08-08
Ginkgo Bioworks Holdings Cut to Hold from Buy by TD Cowen
Ginkgo Bioworks Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-07
Ginkgo Bioworks Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)
TIPRANKS  ·  08-06
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)
Ginkgo Bioworks Q2 FY26 GAAP Net Loss Widens to $57 Million; Revenue Drops 48% to $20 Million
Reuters  ·  08-06
Ginkgo Bioworks Q2 FY26 GAAP Net Loss Widens to $57 Million; Revenue Drops 48% to $20 Million
Ginkgo Bioworks Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
Reuters  ·  08-05
Ginkgo Bioworks Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
Ginkgo Bioworks Holdings Inc Expected to Post a Loss of 91 Cents a Share - Earnings Preview
Reuters  ·  08-04
Ginkgo Bioworks Holdings Inc Expected to Post a Loss of 91 Cents a Share - Earnings Preview
Ginkgo Bioworks Partners with Acies Bio to License Aspergillus Niger Strains for Protein Production
Reuters  ·  08-03
Ginkgo Bioworks Partners with Acies Bio to License Aspergillus Niger Strains for Protein Production
Ginkgo Bioworks to Host Q2 2026 Results Presentation and Q&A Session
Reuters  ·  07-31
Ginkgo Bioworks to Host Q2 2026 Results Presentation and Q&A Session
Since July 23, 30 Fatalities Have Been Identified Through Continued Search Efforts at the Chongqing Pengshui Landslide, With Additional Results Awaiting DNA Analysis
Deep News  ·  07-28
Since July 23, 30 Fatalities Have Been Identified Through Continued Search Efforts at the Chongqing Pengshui Landslide, With Additional Results Awaiting DNA Analysis
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
GlobeNewswire  ·  07-02
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
DNA Match Confirms Family Reunion in Yiwu After Half a Century
Deep News  ·  06-22
DNA Match Confirms Family Reunion in Yiwu After Half a Century
Dragon Boat Festivals Ignite Hearts with Timeless Races
Deep News  ·  06-19
Dragon Boat Festivals Ignite Hearts with Timeless Races
Ginkgo Bioworks shareholders elect directors at annual meeting
Reuters  ·  06-13
Ginkgo Bioworks shareholders elect directors at annual meeting
Awakening the Cultural Spirit: Explore the Warmth of Time in Qingpu
Deep News  ·  06-10
Awakening the Cultural Spirit: Explore the Warmth of Time in Qingpu
Integrated DNA Technologies enters collaboration with Illumina
TIPRANKS  ·  06-01
Integrated DNA Technologies enters collaboration with Illumina
Elicio Therapeutics publishes data on AMP-DNA adjuvant technology
TIPRANKS  ·  06-01
Elicio Therapeutics publishes data on AMP-DNA adjuvant technology

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--